Home・Lista de Ações・Pacira Pharmaceuticals Inc-DE

Pacira Pharmaceuticals Inc-DE

Fechado

SetorSaúde

27.59 3.41

Comprar Vender

Visão Geral

Variação de preço das ações

24h

Atual

Mín

26.19

Máximo

27.59

Indicadores-chave
By Trading Economics
Rendimento	1.3M 2.9M
Vendas	-19M 177M
P/E Médio do Setor	207.077 68.51
EPS	0.6
Margem de lucro	1.644
Funcionários	825
EBITDA	5M 30M

Recomendações
By TipRanks
Recomendações	Comprar
Previsão para 12 meses	+17.64% upside

Dividendos
By Acuity
Próximos Ganhos	5 de nov. de 2026

Estatísticas de Mercado
By TradingEconomics
Capitalização de Mercado	-40M 1.1B
Abertura anterior	24.18
Fecho anterior	27.59

Sentimento de Notícias

By Acuity

50%

175 / 340 Ranking em Healthcare

Pacira Pharmaceuticals Inc-DE Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

4 de ago. de 2026, 19:53 UTC

Pacira Biosciences Inc is higher today, supported by overall market strength and a decline in crude oil prices easing inflation concerns.

3 de ago. de 2026, 20:06 UTC

Pacira Biosciences Inc. shares are higher today, reflecting broader market gains led by major stocks, despite no specific company news identified.

31 de jul. de 2026, 20:02 UTC

Pacira Biosciences Inc's shares are lower today, reaching a session low earlier. The price remains above its 20-day moving average despite the decline.

30 de jul. de 2026, 17:16 UTC

Pacira Biosciences is advancing during Thursday's session, regaining momentum after earlier pulling back from a session high amid broader market optimism.

29 de jul. de 2026, 20:04 UTC

Shares of Pacira Biosciences Inc. are lower today, continuing a decline since Tuesday's close. The stock reached an early high before falling significantly.

28 de jul. de 2026, 19:56 UTC

Event

News

Shares of Pacira Biosciences Inc. are higher, driven by survey findings on orthopedic pain's impact on the workforce and strong interest in non-opioid treatments.

27 de jul. de 2026, 18:51 UTC

Event

News

Pacira Biosciences advances PCRX-201 to commercial manufacturing, allowing patient enrollment in Phase 2 ASCEND study. Shares are higher as investor confidence strengthens.

24 de jul. de 2026, 17:16 UTC

Pacira Biosciences Inc shares are lower today, with no specific news driving the decline. Broader market sentiment is impacted by falling crude oil prices.

22 de jul. de 2026, 18:06 UTC

Pacira Biosciences Inc shares are lower in Wednesday's session, pulling back from earlier gains amid broader market caution and rising crude oil prices.

21 de jul. de 2026, 19:56 UTC

Pacira Biosciences Inc is trading higher, reflecting broader market interest in technology and AI sectors ahead of upcoming earnings reports.

20 de jul. de 2026, 19:46 UTC

Pacira Biosciences Inc shares are trading lower today, having retraced from an earlier high. No specific news was identified to explain the decline.

Comparação entre Pares

Variação de preço

Pacira Pharmaceuticals Inc-DE Previsão

Preço-alvo

By TipRanks

17.64% parte superior

Previsão para 12 meses

Média 31.67 USD 17.64%

Máximo 38 USD

Mínimo 25 USD

Com base em 3 analistas de Wall Street que oferecem metas de preço de 12 meses para Pacira Pharmaceuticals Inc-DE - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

3 ratings

Comprar

Manter

Vender

Com base em 3 analistas que deram avaliações de ações para Pacira Pharmaceuticals Inc-DE - Dist nos últimos 3 meses.

Sentimento

By Acuity

175 / 340 Ranking em Saúde

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

Sobre Pacira Pharmaceuticals Inc-DE

Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature to targeted nerves. It has a development and commercialization, and supply agreement with Aratana Therapeutics, Inc. for NOCITA, a bupivacaine liposome injectable suspension product. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.